Mitchell Horwitz, MD
Duke Health · Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mitchell Horwitz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:09 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04373057 · Prebiotic Galacto-oligosaccharide and Acute GVHDUniversity of Kansas Medical Center · recruiting · Acute GVHD · principal investigator
- Ph3NCT04260698 · Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological MalignanciesGamida Cell ltd · completed · Hematological Malignancies · principal investigator
- Ph3NCT02730299 · Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDSGamida Cell ltd · completed · Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) · study chair
- Ph1/Ph2NCT01816230 · Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HMGamida Cell ltd · completed · Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) · principal investigator
- Ph1NCT01627275 · Naive T-Cell Depleted DLI Following Allo Stem Cell TransplantMitchell Horwitz, MD · completed · Hematological Malignancies · principal investigator
- Ph1/Ph2NCT01280955 · Donor Enhancement With Plerixafor Post Myeloablative Allogeneic TransplantMitchell Horwitz, MD · completed · Failure of Bone Marrow Graft · principal investigator
- Ph1/Ph2NCT01221857 · Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological MalignanciesGamida Cell ltd · completed · Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) · principal investigator
- Ph2NCT00901225 · Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell TransplantDuke University · completed · Multiple Myeloma, Non-Hodgkins Lymphoma, Hodgkins Disease · principal investigator
- Ph1/Ph2NCT00814983 · Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell GraftDuke University · terminated · ALL, ANLL, MDS · principal investigator
- Ph1NCT00737113 · Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood TransplantMitchell Horwitz, MD · terminated · Allogeneic Stem Cell Transplantation · principal investigator
- Ph1NCT00606437 · Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) TransplantsDuke University · completed · Lymphoma, Myeloma, Leukemia · principal investigator
- Ph1NCT00597441 · Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus TransplantationSumitomo Pharma Switzerland GmbH · terminated · Stem Cell Transplantation · principal investigator
- Ph2NCT00004143 · Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure SyndromesDavid Rizzieri, MD · completed · Sickle Cell Anemia, Severe Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Prebiotics to Optimize the Microbiota and Improve Outcomes of AllogeneicHematopoietic Stem Cell TransplantationR01HL151365 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Anthony Sung · fiscal years 2020 to 2024Named on NCT04373057
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.